HOME /Group 2

Group 2 – Drug/ion/cell delivery

Research directions:  

Group leader: (temporary substitute) Prof., Dr.sc.ing. Dagnija Loca

ORCID: https://orcid.org/0000-0001-8056-791X

Prof. Dagnija Loca defended her PhD thesis in Materials Science in 2009. From 2002-2010 Dr. Loca worked in Latvian Institute of Organic Synthesis, Laboratory for Analysis of Biologically Active Compounds, Department of Research and Development, but after the PhD graduation she moved to RTU. Since 2013 Dr. Loca is the director of RTU Rudolfs Cimdins Riga Biomaterials Innovation and Development Centre. Her speciality is materials science, development of drug delivery systems and analytical chemistry as well as management of human resources. In 2012 she was awarded by the L`ORÉAL Latvia "For Women in Science" with the support from UNESCO Latvian National Commission and Latvian Academy of Science for the work "Development of calcium phosphate bone cements/biodegradable polymer composites for local drug delivery" and in 2015 with honorary title “Young Scientist 2015 of Riga Technical University”.

Fields of expertise: controlled release drug delivery systems, bioceramics, hydrogels and composites for local drug delivery, microencapsulation of pharmaceutically active substances.

BBCE project´s main objective is to establish a joint Baltic Biomaterials Centre of Excellence for advanced biomaterials development based on the long-term strategic cooperation between AO Research Institute Davos, Switzerland (ARI) and Friedrich-Alexander University of Erlangen-Nuremberg, Germany (FAU) on the one hand and RTU RBIDC, LIOS, RSU and RSU IS on the other hand.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 857287